Related Experiment Video
Updated: Mar 17, 2026

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.2K
Advances in immunotherapy for melanoma management
Mohammed Dany1,2, Rose Nganga2, Alissar Chidiac2
1a Department of Dermatology and Dermatologic Surgery , Medical University of South Carolina , Charleston , SC , USA.
Human Vaccines & Immunotherapeutics
|July 26, 2016
Summary
Advanced melanoma treatment now focuses on immunotherapy, activating the immune system to fight cancer. This review explores novel immune-based therapies, including checkpoint inhibitors and vaccines, and their clinical success.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Melanoma is a significant cause of mortality in young adults.
- Melanoma tumor cells are recognized as immunogenic.
- Advances in understanding T-cell immune checkpoints have revolutionized treatment strategies.
Purpose of the Study:
- To review the immune signaling and biological mechanisms of novel immunotherapies for advanced melanoma.
- To discuss the clinical benefits of these emerging immune-based treatments.
Main Methods:
- Literature review of recent studies on melanoma immunotherapy.
- Analysis of immune signaling pathways and biological mechanisms.
- Evaluation of clinical trial data for immune-based therapies.
Main Results:
- Immunotherapy, including checkpoint inhibitors, monoclonal antibodies, vaccines, and adoptive T cell therapy, has become a primary approach for advanced melanoma.
- These therapies activate the patient's immune system to target and eliminate melanoma cells.
- Significant clinical benefits have been observed with these novel treatment modalities.
Conclusions:
- Immunotherapy represents a paradigm shift in treating advanced melanoma.
- Understanding immune mechanisms is crucial for developing effective melanoma treatments.
- Immune-based strategies offer promising clinical outcomes for melanoma patients.
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Skin Cancer
6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

